ArticleExperimental hematology & oncology2025

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.

Tingting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.